The ALS Association today applauded the reintroduction of the Accelerating Access to Critical Therapies for ALS (ACT for ALS) Reauthorization Act (H.R. 8205), bipartisan legislation to extend and ...
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve ...
They mourned the loss of running together when the doctor and patient met. He was diagnosed with ALS and she tore tendons in ...
Columbia's Silence ALS program is testing spinal antisense therapy in a high‑risk patient; early EMG tests normalized.
Several patient and disease advocacy organizations have responded to the Center for Drug Evaluation and Research's (CDER) ...
Several years ago our WJXT family was personally touched by ALS, also known as Lou Gehrig’s disease, when our beloved ...
The study is a promising breakthrough that could eventually prove key to understanding the disease’s mysterious origins, its ...
DES MOINES, Iowa — WHO 13’s Lindsey Burrell sat down with Ben Gislason, Voice of the Wild, and Misty Zobel of the ALS Association to discuss the team’s game on Friday, March 20, which benefits the ALS ...
NAARDEN, The Netherlands & WALTHAM, Mass. & BARCELONA, Spain, March 30, 2026--Prilenia Therapeutics B.V. and Ferrerii today announced the first enrollment in the pivotal, 500-participant, randomized, ...
Last year, the annual walk raised $92,318 in support of resources and research for Amyotrophic Lateral Sclerosis.
Trace Neuroscience, a member of BioSpace’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results